Related Experiment Video
Updated: May 5, 2026
Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
Multifunctional liposomes for staged osteoarthritis therapy: From symptom management to regeneration
Qing Yao1, Zhuoxun Huang2, Fuxiang Shangguan3
1Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Abstract:
Osteoarthritis (OA) is a progressive joint disease inadequately addressed by current symptomatic treatments based on therapeutic agents such as NSAIDs, corticosteroids, and viscosupplements, which are limited by poor retention, insufficient efficacy, and a lack of regenerative benefit. Liposomes have recently emerged as versatile carriers that may support stage-aligned interventions from early lubrication to advanced cartilage regeneration. This article summarizes OA pathophysiology and therapeutic targets, with emphasis on the application of liposomes as lubricants, drug delivery systems, and imaging agents. In addition, particular attention is paid to multifunctional liposomes that integrate lubrication with anti-inflammatory, analgesic, pro-regenerative, and imaging capabilities, offering a unified strategy for addressing the complex dynamic progression of OA. Liposome-based strategies are increasingly being recognized as comprehensive and disease-modifying interventions.
Insights
Liposomes offer a promising approach for osteoarthritis (OA) treatment, moving beyond current therapies. These versatile carriers can lubricate joints, deliver drugs, and enable imaging for comprehensive OA management.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Rheumatology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with limited effective treatments.
- Current therapies like NSAIDs and corticosteroids offer only symptomatic relief without regenerative benefits.
- Liposomes are emerging as advanced carriers for OA interventions.
Purpose of the Study:
- To review OA pathophysiology and therapeutic targets.
- To highlight the application of liposomes in OA management.
- To discuss multifunctional liposomes for integrated OA treatment.
Main Methods:
- Literature review of OA pathophysiology and therapeutic targets.
- Analysis of liposome applications as lubricants, drug delivery systems, and imaging agents.
- Exploration of multifunctional liposome strategies for OA.
Main Results:
- Liposomes show potential for lubrication, drug delivery, and imaging in OA.
- Multifunctional liposomes can combine lubrication with anti-inflammatory, analgesic, and pro-regenerative properties.
- Liposome-based strategies offer a unified approach to OA management.
Conclusions:
- Liposomes represent a versatile platform for stage-aligned OA interventions.
- Multifunctional liposomes provide a comprehensive, disease-modifying strategy for OA.
- Liposome technology is advancing OA treatment beyond symptomatic relief.
Related Concept Videos
01:22Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:27Peripheral Artery Disease III: Interprofessional Care
01:11Healing I: Introduction